Gregory Lemberskiy

CEO @ MICSI | MR-Guided PET Enhancement | FDA-Cleared MRI Software | YC-Backed

MICSI· Summer 2023 🇺🇸 Brooklyn, New York, United States

in LinkedIn

2021HealthFellow· On Deck

In tech · since 2011

Company

On Deck

Role

HealthFellow

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

MICSI

Higher resolution MRI with faster scan times.

Summer 2023

Experience

Career

MICSI
Chief Executive Officer · 2018 – Present
2018
New York University
Postdoctoral Researcher, School of Medicine · New York City Metropolitan Area · 2019 – 2023
2019
On Deck
HealthFellow · 2021
2021
NYU School of Medicine
Research Assistant, Center for Biomedical Imaging, NYU School of Medicine · 2012 – 2021
2012
NYU School of Medicine
Teaching Assistant · 2014
2014
Memorial Sloan Kettering Cancer Center
Visiting Researcher · New York City Metropolitan Area · 2019 – 2020
2019
Entrepreneurship Lab (ELabNYC) Bio & Health Tech
Fellow · 2018
2018
Mount Sinai School of Medicine
Research Intern, Jaffe Food Allergy Institute, Mount Sinai School of Medicine · 2011
2011

Bio

Gregory Lemberskiy (CEO) co-founded MICSI with goal of bringing cutting edge image processing tools, that he encountered in the research setting into clinical practice. His PhD work (2019) focused on algorithm development for image enhancement and biophysical modeling of the MRI signal. His methods have been used to enable high-end quality on low field MRI systems through noise reduction (MICSI’s first product) and use MRI to characterize the physical properties of prostate glandular lumen.